⚕ GalenOps CRO console
← 714 (USA)

714-1068

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 714 (USA) (Dr. Clarke) · consented 2013-08-08
Adverse events
6
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

moderate assessed 2026-08-18

Moderate APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-20 (study day 44.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-20 (study day 44.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-20 (study day 44.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-20 (study day 44.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate SKIN IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-08-12 (study day 5.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate SKIN IRRITATION — outcome: RECOVERED/RESOLVED; onset 2013-08-12 (study day 5.0); relationship: PROBABLE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.